Gradishar Named Chief of Hematology and Oncology
William J. Gradishar, MD
William J. Gradishar, MD, the Betsy Bramsen Professor of Breast Oncology & Professor of Medicine in the Division of Hematology and Oncology and Director of the Clinical Network of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, has been appointed Chief of the Division of Hematology and Oncology at the Feinberg School of Medicine, effective April 1, 2018.
Gradishar joined Northwestern as an Assistant Professor of Medicine in 1990, and was promoted to Professor in 2005. He has served in leadership roles throughout his tenure at Northwestern, including director of the Hematology/Oncology Fellowship Program, director of Breast Medical Oncology since 1992, director of the Maggie Daley Center for Women’s Cancer Care since 2010, and most recently as interim chief of the Division.
An internationally recognized expert on breast cancer management, Dr. Gradishar’s clinical and research efforts are focused on the development of novel therapies, including clinical trials designed to precisely target breast cancer at the molecular level. He has served as chair of Lurie Cancer Center's Lynn Sage Breast Cancer Symposium, a nationally recognized, four-day meeting for practicing clinicians, since its inception in 1998.
“Dr. Gradishar is an outstanding physician, scientist and mentor,” said Lurie Cancer Center director, Leonidas Platanias, MD, PhD. “I am confident that his strong leadership will advance the Division of Hematology and Oncology during this important phase of growth for our cancer program.”Dr. Gradishar is chair of the National Comprehensive Cancer Network (NCCN) Breast Cancer Guideline Panel and a member of the Breast Cancer Prevention Panel. He has held numerous leadership positions in the American Society of Clinical Oncology (ASCO), and is a member of the American Association for Cancer Research and the American Federation for Clinical Research. Gradishar has authored over 140 scholarly articles, 45 book chapters, and 5 books. He is the editor-in-chief of NEJM Journal Watch and currently sits on the editorial boards of the Journal of Global Oncology and the Journal of the National Comprehensive Cancer Network, and was recently named among the top breast oncologists in the country as part of a ‘Big Data’ analysis of national benchmarks.Back to top